BMRN Biomarin Pharmaceutical Inc

USD 87.34 -1.27 -1.433247
Icon

Biomarin Pharmaceutical Inc (BMRN) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 87.34

-1.27 (-1.43)%

USD 16.06B

1.03M

USD 103.70(+18.73%)

USD 97.50 (+11.63%)

Icon

BMRN

Biomarin Pharmaceutical Inc (USD)
COMMON STOCK | NSD
USD 87.34
0.00 0
Take a Tour

Biomarin Pharmaceutical Inc (BMRN) Stock Forecast

Show ratings and price targets of :
USD 103.70
(+18.73%)

Based on the Biomarin Pharmaceutical Inc stock forecast from 9 analysts, the average analyst target price for Biomarin Pharmaceutical Inc is USD 103.70 over the next 12 months. Biomarin Pharmaceutical Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Biomarin Pharmaceutical Inc is Bullish , which is based on 10 positive signals and 4 negative signals. At the last closing, Biomarin Pharmaceutical Inc’s stock price was USD 87.34. Biomarin Pharmaceutical Inc’s stock price has changed by +3.84% over the past week, -1.20% over the past month and -4.48% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...